GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xbrane Biopharma AB (STU:7XB) » Definitions » Other Current Receivables

Xbrane Biopharma AB (STU:7XB) Other Current Receivables : €18.76 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Xbrane Biopharma AB Other Current Receivables?

Xbrane Biopharma AB's Other Current Receivables for the quarter that ended in Dec. 2024 was €18.76 Mil.

Xbrane Biopharma AB's quarterly Other Current Receivables declined from Jun. 2024 (€30.68 Mil) to Sep. 2024 (€27.61 Mil) but then stayed the same from Sep. 2024 (€27.61 Mil) to Dec. 2024 (€18.76 Mil).

Xbrane Biopharma AB's annual Other Current Receivables increased from Dec. 2022 (€17.07 Mil) to Dec. 2023 (€24.40 Mil) but then declined from Dec. 2023 (€24.40 Mil) to Dec. 2024 (€18.76 Mil).

Xbrane Biopharma AB Other Current Receivables Historical Data

The historical data trend for Xbrane Biopharma AB's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xbrane Biopharma AB Other Current Receivables Chart

Xbrane Biopharma AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.74 18.98 17.07 24.40 18.76

Xbrane Biopharma AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.40 22.46 30.68 27.61 18.76

Xbrane Biopharma AB Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Xbrane Biopharma AB Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Xbrane Biopharma AB's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Xbrane Biopharma AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xbrane Biopharma AB (STU:7XB) » Definitions » Other Current Receivables
Comparable Companies
OSTO:ACE OSTO:ISOFOL OSTO:XINT OSTO:LIPUM OSTO:GUARD XSAT:CESSA OSTO:IVACC OSTO:IMMU OSTO:KDEV OSTO:CLBIO VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
XBRANE:Sweden 7XB:Germany
Address
Retzius vag 8, Solna, SWE, 171 65
Website
https://www.xbrane.com
Xbrane Biopharma AB is a biotechnology company that develops biosimilars. The company follows drugs on already approved biological drugs that can be introduced at a lower price after the patent expires on the original drug. The company has a patented protein production platform with greater productivity than standard systems for producing proteins in E.coli host cells. Xbrane's product candidate is Ximluci, a ranibizumab biosimilar (original drug Lucentis) used in the treatment of various eye diseases, mainly the wet form of age-related macular degeneration.

Xbrane Biopharma AB Headlines

No Headlines